Data gathered: October 22
AI Stock Analysis - Astrazeneca (AZN)
Analysis generated October 9, 2025. Powered by Chat GPT.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's primary areas of focus are Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. With a diverse product portfolio and strategic partnerships, AstraZeneca aims to improve patient outcomes and provide innovative treatments across the globe.
Stock Alerts - Astrazeneca (AZN)
 |
Astrazeneca | October 10 Val Hoyle (member of U.S. congress) is selling shares |
|
Astrazeneca | October 6 Job postings are down by 17.1% in the last couple of days. |
|
Astrazeneca | October 1 Price is up by 6.3% in the last 24h. |
|
Astrazeneca | September 5 Over the past few months, there has been a noticeable downward trend in Job postings. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Astrazeneca
About Astrazeneca
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $83.88 |
| Target Price | Sign up |
| Volume | 592,330 |
| Market Cap | $262B |
| Year Range | $64.42 - $85.87 |
| Dividend Yield | 1.87% |
| PE Ratio | 31.53 |
| Analyst Rating | 100% buy |
| Earnings Date | November 6 '25 |
| Industry | Drug Manufacturers |
In the news
 |
AstraZeneca PLC (AZN) Presents at ESMO Congress 2025 - SlideshowOctober 21 - SeekingAlpha |
 |
Here's Why Astrazeneca (AZN) is a Strong Momentum StockOctober 19 - Yahoo |
|
Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should KnowOctober 17 - Yahoo |
|
Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?October 13 - Yahoo |
|
AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff ReprieveOctober 13 - Yahoo |
 |
Ameritas Advisory Services LLC Cuts Stock Holdings in AstraZeneca PLC $AZNOctober 7 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 14.5B | 2.47B | 12B | 2.45B | 4.96B | 0.790 |
| Q1 '25 | 13.6B | 2.23B | 11.4B | 2.92B | 5.08B | 1.250 |
| Q4 '24 | 14.9B | 2.73B | 12.2B | 1.5B | 4.43B | 1.050 |
| Q3 '24 | 13.6B | 3.08B | 10.5B | 1.43B | 4.1B | 1.040 |
| Q2 '24 | 12.9B | 2.18B | 10.8B | 1.93B | 4.12B | 0.990 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$192.38 0.3% | 63 |
 |
Eli Lilly and CompanyLLY |
$804.36 0.6% | 59 |
 |
PfizerPFE |
$24.8 0.2% | 57 |
 |
AbbVieABBV |
$230.41 0.4% | 60 |
 |
TherapeuticsMDTXMD |
$1.18 0.9% | 45 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Val Hoyle |
Oct 10, 25 | Sell | $1K - $15K |
| Valerie Hoyle |
Sep 12, 25 | Buy | $1K - $15K |
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
Read more about Astrazeneca (AZN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Astrazeneca?
The Market Cap of Astrazeneca is $262B.
What is Astrazeneca's PE Ratio?
As of today, Astrazeneca's PE (Price to Earnings) ratio is 31.53.
When does Astrazeneca report earnings?
Astrazeneca will report its next earnings on November 6 '25.
What is the current stock price of Astrazeneca?
Currently, the price of one share of Astrazeneca stock is $83.88.
How can I analyze the AZN stock price chart for investment decisions?
The AZN stock price chart above provides a comprehensive visual representation of Astrazeneca's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astrazeneca shares. Our platform offers an up-to-date AZN stock price chart, along with technical data analysis and alternative data insights.
Does AZN offer dividends to its shareholders?
Yes, Astrazeneca (AZN) offers dividends to its shareholders, with a dividend yield of 1.87%. This dividend yield represents Astrazeneca's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Astrazeneca in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Astrazeneca?
Some of the similar stocks of Astrazeneca are Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie, and TherapeuticsMD.
.
